Abstract
We have developed a rapid immunoglobulin G (IgG) and a human serum albumin (HSA) depletion protocol. We depleted both HSA and IgG (> 97%) separately, and in a single procedure. The method is specific and reproducible (RSD < 1.0%), and substantially lowered the detection limit of prostate-specific antigen, a prostate cancer biomarker. The method can be applied to other biomarkers and proteomic studies. Interestingly, the depletion of HSA might not be blankly as beneficial as widely portrayed. Our study suggests the depletion of IgG to be more beneficial than albumin depletion.
Similar content being viewed by others
References
N. L. Anderson and N. G. Anderson, Mol. Cell. Proteomics, 2002, 1, 845.
M. Fountoulakis, J.-F. Juranville, L. Jiang, D. Avila, D. Roder, P. Jakob, P. Berndt, S. Evers, and H. Langen, Amino Acids, 2004, 27, 249.
C. Greenough, R. E. Jenkins, N. R. Kitteringham, M. Pirmohamed, B. K. Park, and S. R. Pennington, Proteomics, 2004, 4, 3107.
L. F. Steel, M. G. Trotter, P. B. Nakajima, T. S. Mattu, G. Gonye, and T. Block, Mol. Cell. Proteomics, 2003, 24, 262.
D. A. Colantonio, C. Dunkinson, D. E. Bovenkamp, and J. E. Van Eyk, Proteomics, 2005, 5, 3831.
O. Chertov, J. T. Simpson, A. Biragyn, T. P. Conrads, T. D. Veenstra, and R. J. Fisher, Expert Rev. Proteomics, 2005, 2, 139.
T. B. Martins, T. D. Jaskowski, C. L. Mouritsen, and H. R. Hill, Clin. Diag. Lab. Immunol., 1995, 2, 98.
D. Hinerfeld, D. Innamorati, J. Pirro, and S. W. Tam, J. Biomol. Technol., 2004, 15, 184.
C. Li and K. H. Lee, Anal. Biochem., 2004, 333, 381.
A. Denizli and E. Piskin, J. Biochem. Biophys. Methods, 2001, 49, 391.
R. Tanaka, T. Yuhi, N. Nagatani, T. Endo, K. Kerman, Y. Takamura, and E. Tamiya, Anal. Bioanal. Chem., 2006, 385, 1414.
[Editorial] J. Clin. Endocrinol. Metab., 1995, 80, 1515.
S. Wesseling, C. Stephan, A. Semjownow, M. Lein, B. Brux, P. Sinha, A. S. Loering, and K. Jung, Clin. Chem., 2003, 49, 887.
F. Oberpenning, S. Hetzel, C. Wining, B. Brandt, A. G. Angelis, A. Heinecke, M. Lein, P. Fornara, H. Schmid, L. Hertle, and A. Semjonow, Eur. Urol., 2003, 43, 478.
C. D. An, T. Yoshiki, G. Lee, and Y. Okada, Cancer Lett., 2001, 162, 135.
I. Sato, M. Sagi, A. Ishiwari, and H. Nishijima, Forensic Sci. Int., 2002, 127, 71.
K. D. Linton and F. C. Hamdy, Cancer Treat. Rev., 2003, 29, 151.
S. R. Potter, T. Reckwitz, and A. W. Partin, J. Andrology, 1999, 20, 449.
S. Roche, L. Tiers, M. Provansal, M.-T. Piva, and S. Lehmann, Proteome Sci., 2006, 4, 20.
T. Yuhi, N. Nagatani, T. Endo, K. Kerman, M. Takata, H. Konaka, M. Namiki, Y. Takamura, and E. Tamiya, J. Immunol. Methods, 2006, 312, 54.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vestergaard, M., Tamiya, E. A Rapid Sample Pretreatment Protocol: Improved Sensitivity in the Detection of a Low-abundant Serum Biomarker for Prostate Cancer. ANAL. SCI. 23, 1443–1446 (2007). https://doi.org/10.2116/analsci.23.1443
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2116/analsci.23.1443